{
  "identifiers": [
    {
      "type": "CUSTOM",
      "details": "reaction index",
      "value": "45"
    },
    {
      "type": "REACTION_TYPE",
      "details": "reaction type",
      "value": "1.3.2 [N-arylation with Ar-X] Chloro Buchwald-Hartwig amination"
    }
  ],
  "inputs": {
    "Base": {
      "components": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "C1=CC=C(C=C1)[O-].[Na+]"
            }
          ],
          "amount": {
            "moles": {
              "value": 0.00016,
              "units": "MOLE"
            }
          },
          "reaction_role": "REAGENT",
          "is_limiting": false
        }
      ]
    },
    "Solvent": {
      "components": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "COCCOC"
            }
          ],
          "amount": {
            "volume": {
              "value": 0.001,
              "units": "LITER"
            }
          },
          "reaction_role": "SOLVENT",
          "is_limiting": false
        }
      ]
    },
    "metal and ligand": {
      "components": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "CC(C1CCCC1P(C2CCCCC2)C3CCCCC3)P(C(C)(C)C)C(C)(C)C.C1CCCC1.[Fe]"
            }
          ],
          "amount": {
            "moles": {
              "value": 2e-05,
              "units": "MOLE"
            }
          },
          "reaction_role": "CATALYST",
          "is_limiting": false
        },
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "CC(=O)O.CC(=O)O.[Pd]"
            }
          ],
          "amount": {
            "moles": {
              "value": 1.28e-05,
              "units": "MOLE"
            }
          },
          "reaction_role": "CATALYST",
          "is_limiting": false
        }
      ]
    },
    "aryl halide": {
      "components": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "CN1CCC2=C(C1=O)C(=CC=C2)NC3=CC(=NC=C3C#N)Cl"
            }
          ],
          "amount": {
            "moles": {
              "value": 0.00016,
              "units": "MOLE"
            }
          },
          "reaction_role": "REACTANT",
          "is_limiting": false
        }
      ]
    },
    "amine": {
      "components": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "CC1=NN(C=C1N)C"
            }
          ],
          "amount": {
            "moles": {
              "value": 0.00032,
              "units": "MOLE"
            }
          },
          "reaction_role": "REACTANT",
          "is_limiting": false
        }
      ]
    }
  },
  "conditions": {
    "temperature": {
      "setpoint": {
        "value": 150.0,
        "precision": 10.0,
        "units": "CELSIUS"
      }
    }
  },
  "notes": {
    "procedure_details": "1,3-dimethyl-1H-pyrazol-4-amine (35.5 mg, 0.32 mmol), 6-chloro-4-(2-methyl-1-oxo-1,2,3,4-tetrahydroisoquinolin-8-ylamino)nicotinonitrile (50 mg, 0.16 mmol)sodium phenolate (18.56 mg, 0.16 mmol),(R)-(-)-1-[(S)-2-(DICYCLOHEXYLPHOSPHINO)FERROCENYL]ETHYLDI-T- BUTYLPHOSPHINE (8.74 mg, 0.02 mmol) and diacetoxypalladium (2.87 mg, 0.01 mmol) were suspended in DME (1 mL) and sealed into a microwave tube. The reaction was heated to 150 Â°C for 30 minutes in the microwave reactor and cooled to RT.  LCMS indicated 47% product, ~8% dimer, ~8% hydrolysed Starting material , Starting material 25% and an unknown 17% @ 2.66 and unknown 12% @ 0.77.  Sample combined with en01521-027 and en01521-034, SCX'd and sent to purification group. The crude product was purified by preparative basic HPLC. Fractions containing the desired compound were evaporated to dryness to afford 6-(1,3-dimethyl-1H-pyrazol-4-ylamino)-4-(2-methyl-1-oxo-1,2,3,4-tetrahydroisoquinolin-8-ylamino)nicotinonitrile (34.0 mg, 54.9 %) as a brown solid.  "
  },
  "outcomes": [
    {
      "products": [
        {
          "identifiers": [
            {
              "type": "SMILES",
              "value": "CC1=NN(C=C1NC2=NC=C(C(=C2)NC3=CC=CC4=C3C(=O)N(CC4)C)C#N)C"
            }
          ],
          "is_desired_product": true,
          "measurements": [
            {
              "type": "YIELD",
              "percentage": {
                "value": 54.89
              }
            }
          ],
          "reaction_role": "PRODUCT"
        }
      ]
    }
  ],
  "provenance": {
    "experimenter": {
      "organization": "AstraZeneca"
    },
    "experiment_start": {
      "value": "05/12/2008"
    },
    "publication_url": "https://chemrxiv.org/engage/chemrxiv/article-details/60c9e3f37792a23bfdb2d471",
    "record_created": {
      "time": {
        "value": "10/19/2021, 12:16:25 PM"
      },
      "person": {
        "name": "Bozhao Nan",
        "organization": "Notre Dame",
        "email": "bnan@nd.edu"
      }
    },
    "record_modified": [
      {
        "time": {
          "value": "Fri Oct 22 22:19:55 2021"
        },
        "person": {
          "username": "github-actions",
          "email": "github-actions@github.com"
        },
        "details": "Automatic updates from the submission pipeline."
      }
    ]
  },
  "reaction_id": "ord-1d37196fb74e494d823157202193321f"
}